drugset / Trial / NCT04755595
Combination Facial Aesthetic Treatment in Millennials
Phase 2
Completed
20 enrolled
State University of New York - Downstate Medical Center
Allergan Sales, LLC · collab
NaSingle-groupOpen-labelTreatment
Summary
With 63% of consumers willing to consider investing in facial aesthetics and 73% of consumers worldwide expecting to invest in aesthetic treatments in the upcoming year, it is imperative to explore patient satisfaction and psychosocial impact of a multimodal aesthetic treatment in a millennial cohort. The investigators hypothesize that a combination approach to facial aesthetic treatment in a millennial cohort will result in increased patient-reported satisfaction in multiple areas, including perception of aging concerns and quality of life.
Timeline
- Start
- 2021-03-09
- Primary completion
- 2021-05-19
- Completion
- 2021-05-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botox Cosmetic | Protein / enzyme biologic | — | — |
Indications
No indication recorded.